Charles D. Hyman’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $23.5M | Buy |
189,656
+2,265
| +1% | +$292K | 1.31% | 23 |
|
|
2024
Q1 | $24.7M | Buy |
187,391
+1,315
| +0.7% | +$162K | 1.37% | 22 |
|
|
2023
Q4 | $20.3M | Buy |
186,076
+3,191
| +2% | +$331K | 1.21% | 25 |
|
|
2023
Q3 | $18.8M | Buy |
182,885
+420
| +0.2% | +$45.3K | 1.22% | 25 |
|
|
2023
Q2 | $21.1M | Buy |
182,465
+3,080
| +2% | +$350K | 1.32% | 23 |
|
|
2023
Q1 | $19.1M | Buy |
179,385
+5,077
| +3% | +$548K | 1.27% | 25 |
|
|
2022
Q4 | $19.3M | Buy |
174,308
+1,797
| +1% | +$184K | 1.32% | 24 |
|
|
2022
Q3 | $14.9M | Buy |
172,511
+14,125
| +9% | +$1.26M | 1.14% | 30 |
|
|
2022
Q2 | $14.4M | Buy |
158,386
+1,963
| +1% | +$174K | 1.05% | 31 |
|
|
2022
Q1 | $12.8M | Sell |
156,423
-525
| -0.3% | -$41.4K | 0.81% | 39 |
|
|
2021
Q4 | $12M | Buy |
156,948
+2,171
| +1% | +$173K | 0.76% | 36 |
|
|
2021
Q3 | $11.6M | Buy |
154,777
+11,933
| +8% | +$908K | 0.81% | 37 |
|
|
2021
Q2 | $11.1M | Sell |
142,844
-4,180
| -3% | -$311K | 0.78% | 38 |
|
|
2021
Q1 | $10.8M | Buy |
147,024
+18,567
| +14% | +$1.37M | 0.79% | 37 |
|
|
2020
Q4 | $10M | Buy |
128,457
+1,838
| +1% | +$141K | 0.8% | 38 |
|
|
2020
Q3 | $10M | Buy |
126,619
+18,746
| +17% | +$1.47M | 0.89% | 34 |
|
|
2020
Q2 | $7.96M | Buy |
107,873
+63,726
| +144% | +$4.8M | 0.77% | 37 |
|
|
2020
Q1 | $3.24M | Buy |
44,147
+9,306
| +27% | +$731K | 0.41% | 60 |
|
|
2019
Q4 | $3.02M | Buy |
34,841
+2,064
| +6% | +$170K | 0.3% | 68 |
|
|
2019
Q3 | $2.63M | Buy |
32,777
+2
| +0% | +$160 | 0.28% | 68 |
|
|
2019
Q2 | $2.62M | Buy |
32,775
+134
| +0.4% | +$10.3K | 0.27% | 66 |
|
|
2019
Q1 | $2.59M | Buy |
32,641
+11,054
| +51% | +$827K | 0.27% | 72 |
|
|
2018
Q4 | $1.57M | Sell |
21,587
-260
| -1% | -$18.4K | 0.19% | 81 |
|
|
2018
Q3 | $1.48M | Sell |
21,847
-1,168
| -5% | -$74.4K | 0.15% | 85 |
|
|
2018
Q2 | $1.33M | Buy |
23,015
+127
| +0.6% | +$7.17K | 0.15% | 86 |
|
|
2018
Q1 | $1.19M | Buy |
22,888
+873
| +4% | +$47.1K | 0.14% | 87 |
|
|
2017
Q4 | $1.18M | Sell |
22,015
-491
| -2% | -$27.2K | 0.14% | 88 |
|
|
2017
Q3 | $1.38M | Buy |
22,506
+2,309
| +11% | +$140K | 0.17% | 84 |
|
|
2017
Q2 | $1.24M | Buy |
20,197
+133
| +0.7% | +$8.1K | 0.16% | 82 |
|
|
2017
Q1 | $1.22M | Sell |
20,064
-17
| -0.1% | -$1.03K | 0.16% | 83 |
|
|
2016
Q4 | $1.13M | Buy |
20,081
+3,094
| +18% | +$181K | 0.16% | 81 |
|
|
2016
Q3 | $1.01M | Buy |
16,987
+527
| +3% | +$30.8K | 0.15% | 84 |
|
|
2016
Q2 | $905K | Sell |
16,460
-1,465
| -8% | -$78K | 0.14% | 89 |
|
|
2016
Q1 | $905K | Buy |
17,925
+427
| +2% | +$20.9K | 0.14% | 87 |
|
|
2015
Q4 | $882K | Sell |
17,498
-1,150
| -6% | -$58K | 0.15% | 85 |
|
|
2015
Q3 | $879K | Sell |
18,648
-1,884
| -9% | -$100K | 0.15% | 86 |
|
|
2015
Q2 | $1.11M | Buy |
20,532
+3
| +0% | +$168 | 0.18% | 84 |
|
|
2015
Q1 | $1.13M | Sell |
20,529
-1,046
| -5% | -$59.2K | 0.18% | 82 |
|
|
2014
Q4 | $1.17M | Buy |
21,575
+2
| +0% | +$111 | 0.19% | 82 |
|
|
2014
Q3 | $1.22M | Buy |
21,573
+1
| +0% | +$56 | 0.2% | 80 |
|
|
2014
Q2 | $1.19M | Sell |
21,572
-417
| -2% | -$22.7K | 0.2% | 86 |
|
|
2014
Q1 | $1.19M | Buy |
21,989
+733
| +3% | +$38K | 0.22% | 86 |
|
|
2013
Q4 | $1.01M | Buy |
21,256
+158
| +0.7% | +$7.22K | 0.19% | 87 |
|
|
2013
Q3 | $958K | Sell |
21,098
-682
| -3% | -$31.1K | 0.19% | 88 |
|
|
2013
Q2 | $965K | Buy |
+21,780
| New | +$973K | 0.2% | 88 |
|
Other funds holding MRK
Charles D. Hyman's MRK Position: Q2 2024 in Review
Charles D. Hyman increased its Merck (MRK) stake by 1.2% in Q2 2024, buying an estimated $292K and bringing the position to 189,656 shares worth $23.5M. The position accounts for 1.31% of the portfolio, ranked #23.
Charles D. Hyman first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $24.7M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Charles D. Hyman held 189,656 shares of Merck worth $23.5M as of Q2 2024.
- Charles D. Hyman bought 2,265 Merck shares in Q2 2024, an estimated $292K.
- Merck made up 1.31% of Charles D. Hyman's portfolio in Q2 2024, its #23 holding.
- Charles D. Hyman first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
- Charles D. Hyman's Merck position peaked at $24.7M in Q1 2024.
- 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.